Pinkas Jan
SEC CIK 2077126 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CBIO | CRESCENT BIOPHARMA, INC. | CSO | 21.6K | — | $34.9K | 3 | 2025-12-15 | 2026-09-16 |
Most active insiders at CBIO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Harwin Peter Evan | Dir, 10% | $18.24M | — |
| 2 | Fairmount Funds Management LLC | Dir, 10% | $12.38M | — |
| 3 | Brumm Joshua T | CEO, Dir | — | $920.8K |
| 4 | McNeill Jonathan | Pres, COO | — | $446.9K |
| 5 | Pinkas Jan | CSO | — | $34.9K |
| 6 | Im Ellie Eunkyung | Chief Medical Off | — | $33.1K |
| 7 | Bispham Barbara Harlin | See Remarks | — | $33.0K |
| 8 | Scalzo Richard William | CFO | — | $30.2K |
| 9 | Lynch Ryan | See Remarks | — | $12.7K |
| 10 | Doughty Christopher Grant | Chief Business Off | — | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-18 16:03 | 2026-09-16 | CBIO | CRESCENT BIOPHARMA, INC. | Pinkas Jan | CSO | S - Sale | $17.90 | -658 | 21.6K | -3% | -$11.8K |
| T | 2026-06-23 16:04 | 2026-06-22 | CBIO | CRESCENT BIOPHARMA, INC. | Pinkas Jan | CSO | S - Sale | $17.99 | -1,288 | 22.2K | -5% | -$23.2K |
| DM | 2025-12-17 | 2025-12-15 | CBIO | CRESCENT BIOPHARMA, INC. | Pinkas Jan | CSO | A - Grant | — | +22.5K | 17.5K | New | — |
Purchase Sale Sale after option exercise All abbreviations